AbCellera Results Presentation Deck

STRONG RESULTS & FOCUS ON KEY PRIORITIES Ab Cellera Q1 2022. BUSINESS UPDATE SUMMARY. 2 NEW programs under contract 6 NEW programs started 1 MOLECULE entered the clinic 158 cumulative programs under contract 84 cumulative programs started >$780M in cash, cash equivalents & marketable securities

View entire presentation